Atherosclerosis and inflammation – from pathogenesis to treatment: current state of affairs (Part I)

Atherosclerosis and atherosclerosis-related cardiovascular diseases are a significant public health concern and a rapidly evolving area of research in both fundamental and clinical medicine. Despite the extensive history of studying, many aspects of atherosclerosis etiology and pathogenesis remain u...

Full description

Saved in:
Bibliographic Details
Main Authors: A. A. Avagimyan, L. V. Kaktursky, O. I. Urazova, A. I. Trofimenko, L. M. Sukiasyan, E. A. Kogan, T. A. Demura, N. V. Pogosova
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2025-04-01
Series:Бюллетень сибирской медицины
Subjects:
Online Access:https://bulletin.ssmu.ru/jour/article/view/5973
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849401802427990016
author A. A. Avagimyan
L. V. Kaktursky
O. I. Urazova
A. I. Trofimenko
L. M. Sukiasyan
E. A. Kogan
T. A. Demura
N. V. Pogosova
author_facet A. A. Avagimyan
L. V. Kaktursky
O. I. Urazova
A. I. Trofimenko
L. M. Sukiasyan
E. A. Kogan
T. A. Demura
N. V. Pogosova
author_sort A. A. Avagimyan
collection DOAJ
description Atherosclerosis and atherosclerosis-related cardiovascular diseases are a significant public health concern and a rapidly evolving area of research in both fundamental and clinical medicine. Despite the extensive history of studying, many aspects of atherosclerosis etiology and pathogenesis remain unclear. Traditionally, the pathogenesis of atherosclerosis has been viewed in terms of the localized accumulation of specific lipoprotein fractions in the arterial wall. However, both innate and adaptive immunity play active roles in atherogenesis. Cells and mediators of the immune system engage in intricate interactions with cellular and extracellular components in all layers of the vascular wall. For this reason, scientific community have reached a consensus on the crucial role of inflammation in the onset, progression, and destabilization of an atherosclerotic plaque. Therefore, atherogenesis can be considered not only as a metabolic disorder, but also as an immunoinflammatory process. The aim of this lecture was to summarize contemporary data regarding the role of inflammation at various stages of the atherosclerotic continuum.
format Article
id doaj-art-ffec54c9aff2458c86b4b675e5994ce2
institution Kabale University
issn 1682-0363
1819-3684
language English
publishDate 2025-04-01
publisher Siberian State Medical University (Tomsk)
record_format Article
series Бюллетень сибирской медицины
spelling doaj-art-ffec54c9aff2458c86b4b675e5994ce22025-08-20T03:37:41ZengSiberian State Medical University (Tomsk)Бюллетень сибирской медицины1682-03631819-36842025-04-0124114115310.20538/1682-0363-2025-1-141-1533145Atherosclerosis and inflammation – from pathogenesis to treatment: current state of affairs (Part I)A. A. Avagimyan0L. V. Kaktursky1O. I. Urazova2A. I. Trofimenko3L. M. Sukiasyan4E. A. Kogan5T. A. Demura6N. V. Pogosova7Mkhitar Heratsi Yerevan State Medical UniversityAvtsyn Research Institute of Human Morphology of the Federal state budgetary scientific institution “Petrovsky National Research Center of Surgery”Siberian State Medical UniversityKuban State Medical University (KubSMU)Mkhitar Heratsi Yerevan State Medical UniversityI.M.Sechenov First Moscow State Medical University (Sechenov University)I.M.Sechenov First Moscow State Medical University (Sechenov University)E.I.Chazov National Medical Research Center for Cardiology; People’s Friendship University of Russia (RUDN University)Atherosclerosis and atherosclerosis-related cardiovascular diseases are a significant public health concern and a rapidly evolving area of research in both fundamental and clinical medicine. Despite the extensive history of studying, many aspects of atherosclerosis etiology and pathogenesis remain unclear. Traditionally, the pathogenesis of atherosclerosis has been viewed in terms of the localized accumulation of specific lipoprotein fractions in the arterial wall. However, both innate and adaptive immunity play active roles in atherogenesis. Cells and mediators of the immune system engage in intricate interactions with cellular and extracellular components in all layers of the vascular wall. For this reason, scientific community have reached a consensus on the crucial role of inflammation in the onset, progression, and destabilization of an atherosclerotic plaque. Therefore, atherogenesis can be considered not only as a metabolic disorder, but also as an immunoinflammatory process. The aim of this lecture was to summarize contemporary data regarding the role of inflammation at various stages of the atherosclerotic continuum.https://bulletin.ssmu.ru/jour/article/view/5973atherosclerosisatherogenesislipoproteinsinflammationatherosclerotic plaqueatheroma
spellingShingle A. A. Avagimyan
L. V. Kaktursky
O. I. Urazova
A. I. Trofimenko
L. M. Sukiasyan
E. A. Kogan
T. A. Demura
N. V. Pogosova
Atherosclerosis and inflammation – from pathogenesis to treatment: current state of affairs (Part I)
Бюллетень сибирской медицины
atherosclerosis
atherogenesis
lipoproteins
inflammation
atherosclerotic plaque
atheroma
title Atherosclerosis and inflammation – from pathogenesis to treatment: current state of affairs (Part I)
title_full Atherosclerosis and inflammation – from pathogenesis to treatment: current state of affairs (Part I)
title_fullStr Atherosclerosis and inflammation – from pathogenesis to treatment: current state of affairs (Part I)
title_full_unstemmed Atherosclerosis and inflammation – from pathogenesis to treatment: current state of affairs (Part I)
title_short Atherosclerosis and inflammation – from pathogenesis to treatment: current state of affairs (Part I)
title_sort atherosclerosis and inflammation from pathogenesis to treatment current state of affairs part i
topic atherosclerosis
atherogenesis
lipoproteins
inflammation
atherosclerotic plaque
atheroma
url https://bulletin.ssmu.ru/jour/article/view/5973
work_keys_str_mv AT aaavagimyan atherosclerosisandinflammationfrompathogenesistotreatmentcurrentstateofaffairsparti
AT lvkaktursky atherosclerosisandinflammationfrompathogenesistotreatmentcurrentstateofaffairsparti
AT oiurazova atherosclerosisandinflammationfrompathogenesistotreatmentcurrentstateofaffairsparti
AT aitrofimenko atherosclerosisandinflammationfrompathogenesistotreatmentcurrentstateofaffairsparti
AT lmsukiasyan atherosclerosisandinflammationfrompathogenesistotreatmentcurrentstateofaffairsparti
AT eakogan atherosclerosisandinflammationfrompathogenesistotreatmentcurrentstateofaffairsparti
AT tademura atherosclerosisandinflammationfrompathogenesistotreatmentcurrentstateofaffairsparti
AT nvpogosova atherosclerosisandinflammationfrompathogenesistotreatmentcurrentstateofaffairsparti